Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,047,859
-
Share change
-
-293,950
-
Total reported value
-
$25,048,554
-
Price per share
-
$1.92
-
Number of holders
-
40
-
Value change
-
-$453,642
-
Number of buys
-
12
-
Number of sells
-
17
Institutional Holders of AVIRAGEN THERAPEUTICS INC - COM (AVIR) as of Q3 2016
As of 30 Sep 2016,
AVIRAGEN THERAPEUTICS INC - COM (AVIR) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,047,859 shares.
The largest 10 holders included
Broadfin Capital, LLC, Krensavage Asset Management, LLC, SENZAR ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., FMR LLC, Stonepine Capital Management, LLC, DEUTSCHE BANK AG\, and GABELLI SECURITIES, INC..
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.